197 related articles for article (PubMed ID: 19603527)
1. Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.
Hodge JC; Park PJ; Dreyfuss JM; Assil-Kishawi I; Somasundaram P; Semere LG; Quade BJ; Lynch AM; Stewart EA; Morton CC
Genes Chromosomes Cancer; 2009 Oct; 48(10):865-85. PubMed ID: 19603527
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.
Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC
Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407
[TBL] [Abstract][Full Text] [Related]
3. The del(7q) subgroup in uterine leiomyomata: genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata.
Xing YP; Powell WL; Morton CC
Cancer Genet Cytogenet; 1997 Oct; 98(1):69-74. PubMed ID: 9309121
[TBL] [Abstract][Full Text] [Related]
4. Translocations in 7q22 define a critical region in uterine leiomyomata.
Sargent MS; Weremowicz S; Rein MS; Morton CC
Cancer Genet Cytogenet; 1994 Oct; 77(1):65-8. PubMed ID: 7923086
[TBL] [Abstract][Full Text] [Related]
5. Deletion 7q in uterine leiomyoma: fluorescence in situ hybridization characterization on primary cytogenetic preparations.
Vanni R; Schoenmakers EF; Andria M
Cancer Genet Cytogenet; 1999 Sep; 113(2):183-7. PubMed ID: 10484989
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic characterization of del(7q) in two uterine leiomyoma-derived cell lines.
Vanni R; Marras S; Schoenmakers EF; Dal Cin P; Kazmierczak B; Senger G; Bullerdiek J; Van de Ven WJ; Van den Berghe H
Genes Chromosomes Cancer; 1997 Mar; 18(3):155-61. PubMed ID: 9071567
[TBL] [Abstract][Full Text] [Related]
7. Two discrete regions of deletion at 7q in uterine leiomyomas.
Ishwad CS; Ferrell RE; Hanley K; Davare J; Meloni AM; Sandberg AA; Surti U
Genes Chromosomes Cancer; 1997 Jul; 19(3):156-60. PubMed ID: 9218996
[TBL] [Abstract][Full Text] [Related]
8. Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas.
Nilbert M; Heim S; Mandahl N; Flodérus UM; Willén H; Mitelman F
Hum Genet; 1990 Oct; 85(6):605-11. PubMed ID: 2227952
[TBL] [Abstract][Full Text] [Related]
9. Chromosome analysis of uterine adenomyosis. Detection of the leiomyoma-associated del(7q) in three cases.
Pandis N; Karaiskos C; Bardi G; Sfikas K; Tserkezoglou A; Fotiou S; Heim S
Cancer Genet Cytogenet; 1995 Apr; 80(2):118-20. PubMed ID: 7736427
[TBL] [Abstract][Full Text] [Related]
10. Delineation of multiple deleted regions in 7q in myeloid disorders.
Tosi S; Scherer SW; Giudici G; Czepulkowski B; Biondi A; Kearney L
Genes Chromosomes Cancer; 1999 Aug; 25(4):384-92. PubMed ID: 10398433
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas.
Ishwad CS; Ferrell RE; Davare J; Meloni AM; Sandberg AA; Surti U
Genes Chromosomes Cancer; 1995 Sep; 14(1):51-5. PubMed ID: 8527384
[TBL] [Abstract][Full Text] [Related]
12. Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma.
Schoenmakers EF; Bunt J; Hermers L; Schepens M; Merkx G; Janssen B; Kersten M; Huys E; Pauwels P; Debiec-Rychter M; van Kessel AG
Genes Chromosomes Cancer; 2013 Jan; 52(1):11-23. PubMed ID: 22965931
[TBL] [Abstract][Full Text] [Related]
13. 7q deletion mapping and expression profiling in uterine fibroids.
Vanharanta S; Wortham NC; Laiho P; Sjöberg J; Aittomäki K; Arola J; Tomlinson IP; Karhu A; Arango D; Aaltonen LA
Oncogene; 2005 Sep; 24(43):6545-54. PubMed ID: 15940248
[TBL] [Abstract][Full Text] [Related]
14. Association of the shrinkage of uterine leiomyoma treated with GnRH agonist and deletion of long arm of chromosome 7.
Takahashi K; Kawamura N; Tsujimura A; Ichimura T; Ito F; Ishiko O; Ogita S
Int J Oncol; 2001 Jun; 18(6):1259-63. PubMed ID: 11351260
[TBL] [Abstract][Full Text] [Related]
15. Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.
van der Heijden O; Chiu HC; Park TC; Takahashi H; LiVolsi VA; Risinger JI; Barrett JC; Berchuck A; Evans AC; Behbakht K; Menzin AW; Liu PC; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Mol Carcinog; 1998 Dec; 23(4):243-7. PubMed ID: 9869453
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
Hodge JC; Morton CC
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
[TBL] [Abstract][Full Text] [Related]
17. PCOLCE deletion and expression analyses in uterine leiomyomata.
Ligon AH; Scott IC; Takahara K; Greenspan DS; Morton CC
Cancer Genet Cytogenet; 2002 Sep; 137(2):133-7. PubMed ID: 12393284
[TBL] [Abstract][Full Text] [Related]
18. Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene.
Ptacek T; Song C; Walker CL; Sell SM
Cancer Genet Cytogenet; 2007 Apr; 174(2):116-20. PubMed ID: 17452252
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC
Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
